Unknown

Dataset Information

0

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment.

ABSTRACT:

SUBMITTER: Yu B 

PROVIDER: S-EPMC7547293 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Azvudine (FNC): a promising clinical candidate for COVID-19 treatment.

Yu Bin B   Yu Bin B   Chang Junbiao J  

Signal transduction and targeted therapy 20201010 1

Similar Datasets

Unknown Budesonide: A promising candidate therapeutic for early COVID-19.
| S-EPMC8327609 | biostudies-literature
Unknown Neopterin: A Promising Candidate Biomarker for Severe COVID-19.
| S-EPMC7866915 | biostudies-literature
Unknown Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials.
| S-EPMC10484631 | biostudies-literature
Unknown Niclosamide-A promising treatment for COVID-19.
| S-EPMC9111792 | biostudies-literature
Unknown Azvudine efficacy in reducing mortality in COVID-19 patients.
| S-EPMC11670479 | biostudies-literature
Unknown A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study.
| S-EPMC7404576 | biostudies-literature
Unknown Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities.
| S-EPMC10188372 | biostudies-literature
Unknown Stem cell therapy: A promising treatment for COVID-19.
| S-EPMC8717529 | biostudies-literature
Unknown Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19.
| S-EPMC10053779 | biostudies-literature
Unknown Molnupiravir: A new candidate for COVID-19 treatment.
| S-EPMC8929331 | biostudies-literature